Luciana Basili Dias Candidíase vulvovaginal em pacientes gestantes

Referências Bibliográficas 98
Shimp LA. Vaginal and vulvovaginal disorders. In: Beraid M, et al. Handbook of
nonprescription drugs, 13ª ed. Washington: American Pharmaceutical Association; 2002. p. 129-
47.
Simões JA, Giraldo PC, Ribeiro Filho AD, Faundes A. Prevalência e fatores de risco associados
à infecções cérvico-vaginais durante a gestação. Rev. Bras. Ginecol. Obstet. 1996; 18 (6): 459-
67.
Sobel JD. Candidal vulvovaginitis. Clin Obstet Gynecol. 1993; 36: 153-12
Sobel JD. Candida vulvovaginitis. Sem. Dermatol. 1996; 15: 17-28.
Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am. J. Obstet.
Gynecol. 1985; 152: 924-35.
Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, et al. Vulvovaginal
candidiasis: Epidemilogic, diagnostic, and therapeutic considerations. Am. J. Obstet. Gynecol.
1998a; 178: 203-11.
Sobel JD, Kapernick PS, Zervos M, et al. Treatment of complicated Candida vaginitis:
comparison of single and seqüencial doses of fluconazole. Am. J. Obstet. Gynaecol. 2001; 185:
363-9.
Sobel JD, Muller G, Cormick Mc. Experimental chronic vaginal candidíases in rats.
Sabouraudia. 1998b; 5: 199-206.
Sobel JD. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin Infect Dis.
1992; 14: 148-53.
Sobel JD. Vaginitis. New Engl. J. Med.1997; 337: 1896-903.
Sobel JD, Zervos M, Reed BD, Hooton T, Soper D, Nyirjesy P, et al. Fluconazole Susceptibility
of Vaginal Isolates Obtained from Women with Complicated Candida Vaginitis: Clinical
Implications. Antimicrob. Agents Chemother. 2003; 47: 34-8.